Literature DB >> 23041568

Peroxisome proliferator-activated receptor γ B cell-specific-deficient mice have an impaired antibody response.

Sesquile Ramon1, Simona Bancos, Thomas H Thatcher, Thomas I Murant, Safiehkhatoon Moshkani, Julie M Sahler, Andrea Bottaro, Patricia J Sime, Richard P Phipps.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor superfamily. PPARγ, a ligand-activated transcription factor, has important anti-inflammatory and antiproliferative functions, and it has been associated with diseases including diabetes, scarring, and atherosclerosis, among others. PPARγ is expressed in most bone marrow-derived cells and influences their function. PPARγ ligands can stimulate human B cell differentiation and promote Ab production. A knowledge gap is that the role of PPARγ in B cells under physiological conditions is not known. We developed a new B cell-specific PPARγ (B-PPARγ) knockout mouse and explored the role of PPARγ during both the primary and secondary immune response. In this article, we show that PPARγ deficiency in B cells decreases germinal center B cells and plasma cell development, as well as the levels of circulating Ag-specific Abs during a primary challenge. Inability to generate germinal center B cells and plasma cells is correlated to decreased MHC class II expression and decreased Bcl-6 and Blimp-1 levels. Furthermore, B-PPARγ-deficient mice have an impaired memory response, characterized by low titers of Ag-specific Abs and low numbers of Ag-experienced, Ab-secreting cells. However, B-PPARγ-deficient mice have no differences in B cell population distribution within primary or secondary lymphoid organs during development. This is the first report, to our knowledge, to show that, under physiological conditions, PPARγ expression in B cells is required for an efficient B cell-mediated immune response as it regulates B cell differentiation and Ab production.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23041568      PMCID: PMC3490033          DOI: 10.4049/jimmunol.1200956

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

Authors:  E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.

Authors:  B H Ye; G Cattoretti; Q Shen; J Zhang; N Hawe; R de Waard; C Leung; M Nouri-Shirazi; A Orazi; R S Chaganti; P Rothman; A M Stall; P P Pandolfi; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

3.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

4.  Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.

Authors:  Sarah G Harris; Richard P Phipps
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

5.  Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis.

Authors:  K Setoguchi; Y Misaki; Y Terauchi; T Yamauchi; K Kawahata; T Kadowaki; K Yamamoto
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

6.  Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12,14)(12,14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells.

Authors:  J Padilla; K Kaur; H J Cao; T J Smith; R P Phipps
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 7.  Nuclear receptors: doubling up in the lung.

Authors:  Stuart N Farrow
Journal:  Curr Opin Pharmacol       Date:  2008-03-14       Impact factor: 5.547

8.  Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells.

Authors:  Kuo-I Lin; Cristina Angelin-Duclos; Tracy C Kuo; Kathryn Calame
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation.

Authors:  Tatiana M Garcia-Bates; Carolyn J Baglole; Matthew P Bernard; Thomas I Murant; Patricia J Simpson-Haidaris; Richard P Phipps
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  Peroxisome proliferator activated receptor ligands as regulators of airway inflammation and remodelling in chronic lung disease.

Authors:  Jane Elizabeth Ward; Xiahui Tan
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more
  14 in total

1.  The specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?

Authors:  Sesquile Ramon; Steven F Baker; Julie M Sahler; Nina Kim; Eric A Feldsott; Charles N Serhan; Luis Martínez-Sobrido; David J Topham; Richard P Phipps
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Corticosteroids inhibit anti-IgE activities of specialized proresolving mediators on B cells from asthma patients.

Authors:  Nina Kim; Thomas H Thatcher; Patricia J Sime; Richard P Phipps
Journal:  JCI Insight       Date:  2017-02-09

Review 3.  PPARγ and the Innate Immune System Mediate the Resolution of Inflammation.

Authors:  Amanda Croasdell; Parker F Duffney; Nina Kim; Shannon H Lacy; Patricia J Sime; Richard P Phipps
Journal:  PPAR Res       Date:  2015-12-02       Impact factor: 4.964

4.  DNA cytosine hydroxymethylation levels are distinct among non-overlapping classes of peripheral blood leukocytes.

Authors:  Natalie M Hohos; Kevin Lee; Lexiang Ji; Miao Yu; Muthugapatti M Kandasamy; Bradley G Phillips; Clifton A Baile; Chuan He; Robert J Schmitz; Richard B Meagher
Journal:  J Immunol Methods       Date:  2016-05-06       Impact factor: 2.303

5.  Neonatal Bisphenol A Exposure Affects the IgM Humoral Immune Response to 4T1 Breast Carcinoma Cells in Mice.

Authors:  Ricardo Hernández Avila; Margarita I Palacios-Arreola; Karen E Nava-Castro; Jorge Morales-Montor; Pedro Ostoa-Saloma
Journal:  Int J Environ Res Public Health       Date:  2019-05-20       Impact factor: 3.390

6.  Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors.

Authors:  Carolyn M Nielsen; Ane Ogbe; Isabela Pedroza-Pacheco; Susanne E Doeleman; Yue Chen; Sarah E Silk; Jordan R Barrett; Sean C Elias; Kazutoyo Miura; Ababacar Diouf; Martino Bardelli; Rebecca A Dabbs; Lea Barfod; Carole A Long; Barton F Haynes; Ruth O Payne; Angela M Minassian; Todd Bradley; Simon J Draper; Persephone Borrow
Journal:  Cell Rep Med       Date:  2021-02-22

Review 7.  PPAR agonists as effective adjuvants for COVID-19 vaccines, by modifying immunogenetics: a review of literature.

Authors:  Antoine Fakhry AbdelMassih; Rahma Menshawey; Jumana H Ismail; Reem J Husseiny; Yousef M Husseiny; Shenoda Yacoub; Aya Kamel; Rafeef Hozaien; Elaria Yacoub; Esraa Menshawey; Abanoub Abdelmalek; Ahmed Abouelazaem; Ahmed Elhatw; Ahmed Aboelmaaty; Alaaelrahman Shahib; Amany Mansour; Aya Kamal; Basant Mohamed; Bemen Atif; Beshoy Ghabreal; Catherine Abdelmalak; David Ibrahim; Ebtesam Elsaify; Farah Magdy; Farid G Hanna; Hadeer Hafez; Hafsa Dahir; Kerlos Merhom; Maram Ahmed; Mariam Bishara; Mina Tawfik; Mina Youssef; Mohamed El Sharnouby; Mourad Hamouda; Musheera Ammar; Nada Ali; Nada Daniel; Nadine El-Husseiny; Noha Abdelraouf; Nuran K Abdelhameed; Radwa Ahmed; Radwa Othman; Rahma Mohamadein; Rana Allam; Rana Elgendy; Rana Shebl; Saged Elsherbiney; Sarah Fouad; Sara Emel; Sara Owais; Sarah Hetta; Samah El-Saman; Shaimaa Abdelalim; Sherin Galal; Yara Asar; Yara Osman; Yasmeen Khalaf; Youstina Aziz; Yousra Khafagy; Nervana Gamal; Biagio Castaldi
Journal:  J Genet Eng Biotechnol       Date:  2021-05-31

8.  Targeted Mutation of Nuclear Bone Morphogenetic Protein 2 Impairs Secondary Immune Response in a Mouse Model.

Authors:  Daniel S Olsen; Wesley A Goar; Brandt A Nichols; K Tyson Bailey; S Loyd Christensen; Kayla R Merriam; Paul R Reynolds; Eric Wilson; K Scott Weber; Laura C Bridgewater
Journal:  Biomed Res Int       Date:  2015-08-23       Impact factor: 3.411

9.  Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice.

Authors:  Anne Wilson; He Fu; Mariano Schiffrin; Carine Winkler; Meriem Koufany; Jean-Yves Jouzeau; Nicolas Bonnet; Federica Gilardi; François Renevey; Sanjiv A Luther; David Moulin; Béatrice Desvergne
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

10.  In vivo liposomal delivery of PPARα/γ dual agonist tesaglitazar in a model of obesity enriches macrophage targeting and limits liver and kidney drug effects.

Authors:  Victoria Osinski; Dustin K Bauknight; Siva Sai Krishna Dasa; Matthew J Harms; Tobias Kroon; Melissa A Marshall; James C Garmey; Anh T Nguyen; Julia Hartman; Aditi Upadhye; Prasad Srikakulapu; Andrea Zhou; Gavin O'Mahony; Alexander L Klibanov; Kimberly A Kelly; Jeremie Boucher; Coleen A McNamara
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.